BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -22.35 Million USD | 38.07% |
| 2021 | -34.92 Million USD | -822.38% |
| 2020 | -3.78 Million USD | 2.81% |
| 2019 | -3.89 Million USD | 76.79% |
| 2018 | -16.78 Million USD | -969.33% |
| 2017 | -1.56 Million USD | 13.63% |
| 2016 | -1.81 Million USD | -87.49% |
| 2015 | -969.44 Thousand USD | -57.05% |
| 2014 | -617.29 Thousand USD | -242.63% |
| 2013 | -180.16 Thousand USD | -304.65% |
| 2012 | 88.03 Thousand USD | -95.7% |
| 2011 | 2.04 Million USD | -52.44% |
| 2010 | 4.3 Million USD | -9.91% |
| 2009 | 4.77 Million USD | 30.75% |
| 2008 | 3.65 Million USD | 76.57% |
| 2007 | 2.06 Million USD | 161.54% |
| 2006 | 790.96 Thousand USD | 298.11% |
| 2005 | -399.25 Thousand USD | -15.94% |
| 2004 | -344.35 Thousand USD | -17.9% |
| 2003 | -292.07 Thousand USD | 11.75% |
| 2002 | -330.97 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -884.2 Thousand USD | 91.98% |
| 2023 Q2 | 1.05 Million USD | 219.22% |
| 2023 Q3 | -3.12 Million USD | -396.86% |
| 2022 Q4 | -11.02 Million USD | -196.89% |
| 2022 FY | -21.62 Million USD | 38.07% |
| 2022 Q3 | -3.71 Million USD | 43.25% |
| 2022 Q1 | -2.74 Million USD | 90.76% |
| 2022 Q2 | -6.54 Million USD | -138.82% |
| 2021 Q2 | -275.98 Thousand USD | 91.72% |
| 2021 Q1 | -3.33 Million USD | -31.62% |
| 2021 FY | -34.92 Million USD | -822.38% |
| 2021 Q3 | -1.7 Million USD | -517.22% |
| 2021 Q4 | -29.67 Million USD | -1641.97% |
| 2020 Q1 | -2.19 Million USD | 10.94% |
| 2020 Q3 | -1.9 Million USD | -141.16% |
| 2020 Q4 | -2.53 Million USD | -32.6% |
| 2020 FY | -3.78 Million USD | 2.81% |
| 2020 Q2 | 4.64 Million USD | 311.41% |
| 2019 Q1 | -567.59 Thousand USD | 96.04% |
| 2019 FY | -3.89 Million USD | 76.79% |
| 2019 Q4 | -2.46 Million USD | -352.63% |
| 2019 Q3 | -544.46 Thousand USD | 36.84% |
| 2019 Q2 | -862.09 Thousand USD | -51.89% |
| 2018 FY | -16.78 Million USD | -969.33% |
| 2018 Q1 | -499.69 Thousand USD | -7.4% |
| 2018 Q2 | -1.64 Million USD | -230.1% |
| 2018 Q3 | -310.11 Thousand USD | 81.2% |
| 2018 Q4 | -14.32 Million USD | -4519.96% |
| 2017 FY | -1.56 Million USD | 13.63% |
| 2017 Q2 | -261.33 Thousand USD | 38.4% |
| 2017 Q1 | -424.23 Thousand USD | 31.16% |
| 2017 Q3 | -418.95 Thousand USD | -60.32% |
| 2017 Q4 | -465.28 Thousand USD | -11.06% |
| 2016 Q2 | -276.49 Thousand USD | 49.09% |
| 2016 FY | -1.81 Million USD | -87.49% |
| 2016 Q1 | -543.14 Thousand USD | 28.24% |
| 2016 Q4 | -616.26 Thousand USD | -61.48% |
| 2016 Q3 | -381.63 Thousand USD | -38.03% |
| 2015 Q1 | -86.05 Thousand USD | 81.31% |
| 2015 Q3 | -6519.00 USD | 94.57% |
| 2015 FY | -969.44 Thousand USD | -57.05% |
| 2015 Q4 | -756.86 Thousand USD | -11510.19% |
| 2015 Q2 | -120 Thousand USD | -39.46% |
| 2014 Q1 | -109.73 Thousand USD | 49.36% |
| 2014 FY | -617.29 Thousand USD | -242.63% |
| 2014 Q2 | -374.73 Thousand USD | -241.49% |
| 2014 Q4 | -460.5 Thousand USD | -240.53% |
| 2014 Q3 | 327.68 Thousand USD | 187.44% |
| 2013 Q2 | 52.01 Thousand USD | 432.69% |
| 2013 Q3 | -25.26 Thousand USD | -148.56% |
| 2013 Q4 | -216.68 Thousand USD | -757.75% |
| 2013 Q1 | 9765.00 USD | -85.65% |
| 2013 FY | -180.16 Thousand USD | -304.65% |
| 2012 Q3 | 1016.00 USD | -94.61% |
| 2012 FY | 88.03 Thousand USD | -95.7% |
| 2012 Q4 | 68.05 Thousand USD | 6598.13% |
| 2012 Q1 | 111.00 USD | -99.99% |
| 2012 Q2 | 18.85 Thousand USD | 16885.59% |
| 2011 Q3 | 71.08 Thousand USD | -85.74% |
| 2011 Q1 | 292.32 Thousand USD | -41.0% |
| 2011 FY | 2.04 Million USD | -52.44% |
| 2011 Q4 | 1.18 Million USD | 1566.25% |
| 2011 Q2 | 498.63 Thousand USD | 70.57% |
| 2010 FY | 4.3 Million USD | -9.91% |
| 2010 Q1 | 367.18 Thousand USD | -72.77% |
| 2010 Q2 | 1.37 Million USD | 273.2% |
| 2010 Q3 | 2.06 Million USD | 51.04% |
| 2010 Q4 | 495.5 Thousand USD | -76.06% |
| 2009 Q1 | 441.91 Thousand USD | -54.75% |
| 2009 Q2 | 808.94 Thousand USD | 83.06% |
| 2009 Q3 | 2.17 Million USD | 169.05% |
| 2009 Q4 | 1.34 Million USD | -38.04% |
| 2009 FY | 4.77 Million USD | 30.75% |
| 2008 Q1 | 579.38 Thousand USD | -21.05% |
| 2008 Q4 | 976.6 Thousand USD | -8.31% |
| 2008 Q3 | 1.06 Million USD | 0.26% |
| 2008 Q2 | 1.06 Million USD | 83.36% |
| 2008 FY | 3.65 Million USD | 76.57% |
| 2007 Q4 | 733.84 Thousand USD | 26.98% |
| 2007 Q2 | 837.73 Thousand USD | 1136.97% |
| 2007 Q1 | -80.78 Thousand USD | -106.92% |
| 2007 FY | 2.06 Million USD | 161.54% |
| 2007 Q3 | 577.91 Thousand USD | -31.01% |
| 2006 Q2 | -72.38 Thousand USD | 23.65% |
| 2006 Q3 | -209.76 Thousand USD | -189.8% |
| 2006 Q4 | 1.16 Million USD | 656.78% |
| 2006 FY | 790.96 Thousand USD | 298.11% |
| 2006 Q1 | -94.8 Thousand USD | -35.28% |
| 2005 Q4 | -70.08 Thousand USD | 48.96% |
| 2005 FY | -399.25 Thousand USD | -15.94% |
| 2005 Q3 | -137.29 Thousand USD | -41.3% |
| 2005 Q1 | -94.72 Thousand USD | 6.81% |
| 2005 Q2 | -97.16 Thousand USD | -2.58% |
| 2004 Q3 | -100.48 Thousand USD | -19.48% |
| 2004 Q1 | -58.13 Thousand USD | 36.08% |
| 2004 Q2 | -84.1 Thousand USD | -44.67% |
| 2004 FY | -344.35 Thousand USD | -17.9% |
| 2004 Q4 | -101.64 Thousand USD | -1.15% |
| 2003 FY | -292.07 Thousand USD | 11.75% |
| 2003 Q4 | -90.95 Thousand USD | -85.9% |
| 2003 Q3 | -48.92 Thousand USD | 51.5% |
| 2003 Q1 | -51.32 Thousand USD | 46.9% |
| 2003 Q2 | -100.87 Thousand USD | -96.54% |
| 2002 Q2 | -77.91 Thousand USD | 23.55% |
| 2002 FY | -330.97 Thousand USD | 0.0% |
| 2002 Q3 | -54.47 Thousand USD | 30.09% |
| 2002 Q1 | -101.91 Thousand USD | 0.0% |
| 2002 Q4 | -96.66 Thousand USD | -77.46% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -19.93 Million USD | -12.128% |
| China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -427.906% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | 8.432% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | 8.432% |
| Leafly Holdings, Inc. | -9.49 Million USD | -135.342% |
| Leafly Holdings, Inc. | -9.49 Million USD | -135.342% |
| LifeMD, Inc. | -20.59 Million USD | -8.53% |
| LifeMD, Inc. | -20.59 Million USD | -8.53% |
| TRxADE HEALTH, Inc. | -17.84 Million USD | -25.271% |
| PetMed Express, Inc. | -7.46 Million USD | -199.474% |
| Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.741% |